C
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Price:
7.79
USD
16.1%
Market Closed
Market Cap:
$18.2m
Cash Flow Statement
Cash Flow Statement
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(10)
|
(12)
|
(15)
|
(11)
|
(13)
|
(14)
|
(14)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
5
|
5
|
5
|
1
|
2
|
2
|
2
|
|
| Change in Working Capital |
(0)
|
0
|
0
|
2
|
1
|
0
|
0
|
|
| Cash from Operating Activities |
(5)
N/A
|
(7)
-28%
|
(9)
-32%
|
(7)
+19%
|
(10)
-38%
|
(12)
-15%
|
(12)
-1%
|
|
| Investing Cash Flow | ||||||||
| Other Items |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-51%
|
(0)
N/A
|
(0)
-18%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
12
|
12
|
14
|
9
|
11
|
13
|
12
|
|
| Net Issuance of Debt |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
12
N/A
|
12
N/A
|
13
+13%
|
9
-33%
|
11
+22%
|
12
+12%
|
11
-7%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
7
N/A
|
5
-23%
|
4
-13%
|
2
-63%
|
1
-52%
|
1
-31%
|
(1)
N/A
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(5)
N/A
|
(7)
-28%
|
(9)
-32%
|
(7)
+19%
|
(10)
-38%
|
(12)
-15%
|
(12)
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
